Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)

NCT00552565 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

711

Enrollment

OTHER

Sponsor class

Conditions

Irritable Bowel Syndrome With Diarrhea

Interventions

DRUG: Rezular 15mg
DRUG: Placebo
DRUG: Rezular
DRUG: Rezular

Sponsor

AGI Therapeutics, Inc.